【正文】
tly cover CTC as a screening modality,第二十四頁,共二十七頁。,25,2008 CRC Guidelines continue to emphasize options because:,Evidence does not yet support any single test as “best” Uncertainty exists about performance of different screening methods with regard to benefits, harms, and costs (especially on programmatic basis) Uptake of screening remains disappointingly low Individuals differ in their preferences for one test or another Primary care physicians differ in their ability to offer, explain, or refer patients to all options equally Access is uneven geographically, and in terms of test charges and insurance coverage,第二十五頁,共二十七頁。,26,If tests that can prevent CRC are preferred, why not recommend them alone?,Greater patient requirements for successful completion Endoscopic and radiologic exams require a bowel prep and an office or facility visit Higher potential for patient injury than fecal testing Risk levels vary between tests, facilities, practitioners Patient preference Many individuals don’t want an invasive test or a test that requires a bowel prep Some prefer to have screening in the privacy of their home Some may not have access to the invasive tests due to lack of coverage or local resources,第二十六頁,共二十七頁。,內(nèi)容(n232。ir243。ng)總結(jié),CT虛擬結(jié)腸鏡。散發(fā)(s224。nfā) (一般危險因素) (65%–85%)。遺傳性非息肉性結(jié)腸直腸癌 (HNPCC) (5%)。近一半多一點(diǎn)的超過50歲的美國人有進(jìn)行近期的結(jié)腸直腸癌篩查。害怕, 難為情, 不舒服。Patient preference,第二十七頁,共二十七頁。,